Eight infants with stage 3+ retinopathy of prematurity (ROP) were treated using the diode laser through a bin ocular indirect ophthalmoscope. Two infants with zone I disease were treated prethreshold as soon as the signs of plus disease developed. Successful regression was achieved in all cases, though 3 infants required repeat treatment. All infants were followed up for a minimum of 3 months. Keeler acuity scores were in the normal range in 4 of the 8 infants.
Enhanced survival of very-low-birth weight infants with the introduction of new treatments in neonatal care has increased the incidence of blindness due to retinopathy of prematurity (ROP). 12 Xenon arc photocoagulation for severe ROP was first used in 1968 by Nagata.' Subsequent work with the argon laser confirmed the efficacy of photocoagulation in the management of ROP'�5 Practical limitations of the argon laser delivery system in the treatment of neonates restric ted its use and led to the common acceptance of cryo therapy. The American Multicenter Trial for Retinopathy of Prematurity (CryoROP)" confirmed previous clinical impressions by demonstrating a significant reduction in unfavourable outcome in the treatment of stage 3 thresh old disease using this method. The advent of a delivery system on the indirect ophthalmoscope. and lightweight portable machines, has made laser treatment a practical alternative to cryotherapy, leading to a re-evaluation of this technique. Argon laser7•K and diode laserY have both been reported as being successful in treating stage 3 threshold disease. In this study the use of the diode laser was evaluated in 8 infants and the 3 month visual outcome described. 10 All but 2 of the infants were treated at or beyond threshold disease. Threshold disease is defined as 5 or more contiguous (or 8 cumulative) clock-hours of stage 3 in zone I or zone II in the presence of plus disease. Two infants with zone 1 disease were treated prethreshold as soon as plus disease developed.
PATIENTS AND METHODS
All infants of less than 32 weeks gestation and/or with a birthweight of less than or equal to 1500 g were screened for ROP as previously described. I I Six of the infants were nursed in the Regional Neonatal Intensive Care Unit (NICU); 1 was referred for screening and treatment and I was referred for treatment from a peripheral unit having been screened by the local ophthalmologist.
Treatment was carried out as soon as was practically possible: within 48 hours in 5 cases and 72 hours in 3 cases. Infants were treated in a converted isolation room off the NICU. The pupils were dilated with 0.5% cyclo pentolate and 2.5% phenylephrine drops prior to treat ment. The infants were treated under a general anaesthetic administered by the neonatologist. They were paralysed with pancuronium, ventilated on an air/oxygen mixture and fentanyl 15!lg/kg was used for analgesia.
Contiguous laser bums were placed just anterior to the ridge and in a scatter fashion throughout the rest of the avascular retina. A scleral depressor (Osbourne and Sim mons, UK) designed by D.Le. was used to facilitate treat ment of the peripheral retina. Tr eatment was carried out using a diode laser with a wavelength of 800 nm (Nidek) or 810 nm (Keeler). A 28 dioptre lens was used, pro ducing a spot size of about 600 11m diameter. Power suf ficient to produce a dull grey/white reaction ranged from 390 to 1100 mW with apulse duration of 0.1-0.2 seconds.
Post-operatively the infants were kept ventilated until breathing spontaneously. Chloramphenicol ointment q.d.s. and homatropine 1 % eye drops b.d. were admin istered post-operatively for 3 days. All infants were reviewed 10 days after treatment. If the disease showed signs of regressing the infants were then reviewed fort nightly for up to four visits.
Persistent plus disease was retreated within 48 hours. Retreatment was necessary in 3 infants, 2 because of fail ure to show signs of regression. These two infants had fill-in laser to the previously applied scatter treatment. The third case had initially shown complete regression but 32 days following treatment neovascular fronds were noted projecting into the vitreous at the vascular/avascular junc tion (Fig. 1) . Cryotherapy was applied contiguously to the avascular retina as the laser was not available.
All infants were reviewed at 3 months from term for assessment of vision, orthoptic status, refraction and fun dal examination. Grating acuity scores were recorded using Keeler acuity cards. The acuities were measured with both eyes open as the infants generally objected to occlusion of either eye. The infant in whom only one eye was treated was able to overcome a 10 base out prism and we have assumed, with fusion present, that the uniocular visions would be equal. Refractions were carried out using 1 % cyclopentolate.
RESULTS
In this study 8 infants were treated with diode laser. Asym metrical disease occurred in 1 baby and symmetrical disease in the rest, resulting in 15 eyes being treated. The disease regressed completely in all 15 eyes, though 6 eyes required repeat treatment. The gestational ages ranged from 23 to 26 weeks and the birthweights from 576 to 1160 g ( Table 1 ). The median post-menstrual age at trcat- 3 weeks (range 34--43 weeks) and the median age at treatment 78 days (range 69-118 days). All the infants demonstrated plus disease and an average of 8 clock-hours of stage 3 was present. However, 2 patients (cases 4 and 8) had prethreshold zone I disease and were treated as soon as plus disease was noted. In 5 eyes the disease was located in anterior/mid zone II; in 6 eyes in posterior zone II (in these cases the disease dipped into zone I temporally); and 4 eyes had zone I disease. The average number of laser applications required was 845 (range 327-1441).
The treatment was successful in all cases. In 2 patients (cases 6 and 7) retreatment was deemed necessary as there was no resolution of plus disease. In case 3 regression was thought to have occurred but 32 days following treatment neovascular fronds were visible extending into the vit reous (Fig. 1) . The infant was successfully treated with cryotherapy, though one eye has developed macular ectopia.
Treatment complications were limited to variability of the burn intensity resulting in a rupture of Bruch's mem brane associated with a faintly audible 'pop' in 2 patients. No systemic complications occurred during the procedure and the subsequent post-operative course was uneventful.
The grating acuity in 4 infants was at or above the lower limit of normal (Fig. 2) . However, in the remaining 4 patients the acuities were below normal. Two infants (cases 2 and 4) had acuities of 0.18 and 0.65 cycles/degree respectively; both had had grade 4 intraventricular haem orrhages (IYH). The other 2 infants (cases 5 and 8) would not respond during the vision testing procedure though some level of vision was present; they had had grade 4 IYH and had required ventriculo-peritoneal shunts. The refractive errors ranged from +4.00 to -4.00 dioptres spherical equivalent (SE).
DISCUSSION
The Multicenter CryoROP Trial has shown the effective ness of treating threshold ROP using cryotherapy." The advent of portable lasers delivered through a binocular indirect ophthalmoscope facilitates treatment of this con dition, using a modality that is currently used for other ischaemic retinal vascular conditions such as diabetes and vein occlusions. McNamara et al} in a prospective ran domised trial of cryotherapy versus argon laser, demon strated that laser treatment was as effective as cryotherapy.
More recently Hunter et al.9 in another randomised trial comparing diode laser with cryotherapy also found laser to be effective, though the numbers were too small for statistical analysis. In our study we have shown that diode laser was successful in causing regression of stage 3 threshold disease and prethreshold zone I disease.
Laser photocoagulation has a number of advantages over cryotherapy. In our own experience of treating infants using either method, laser is tolerated far better with no bradycardias or arrhythmias during the procedure. The treatment of posterior disease is far easier, avoiding the necessity of a conjunctival incision. Scleral indentation is whether such complications will occur in laser-treated eyes but the diode laser burns have been shown to be less destructive than cryotherapy. 14 4 * Lower Limit of
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Months Fig. 2 . Keeler acuity at 3 months in diode-laser-treated inj'ants. Iris clipping has been described as a complication of some types of diode laser but did not occur in our series. However, in our other 4 cases with no neurological seljue lae the visual acuities were normal. Longitudinal data reported by Birch and Spencer22 have suggested that the early grating acuity is predictive of the long-term visual outcome. The CryoROP 3/:> Year Outcome has shown no significant change in the percentage of eyes with a favour able structural outcome at I year and 3/:> years. but the functional results were different. 2\ At I year the grating acuity showed a 37.8GYr. reduction in unfavourable out come but at 3/'2 years this had fallen to 20.1 %. This is because at I year lower acuity values are still in the normal range. It is thus too early to predict what the final visual results will be from diode laser treatment. In conclusion. although the numbers in the study are small, we have demonstrated that diode laser treatment for stage 3 ROP is successful in causing regression of the disease. The procedure is well tolerated. easy to admin ister and laser is now our preferred method of treatment.
